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L IVER xenografting implies that most of the comple-
ment (C) in the recipients will be produced by the 
graft. It is known that membrane-bound proteins have the 
property of homologous restriction; ie. they inhibit MAC-
mediated lysis only when the terminal C components are 
from the same species as the cells on which these proteins 
are expressed. I To test the hypothesis that this could be a 
mechanism of protection from hyperacute rejection, we 
transplanted hamster hearts into stable hamster-to-rat liver 
xenograft recipients (OL T). Minutes later, hyperimmune 
serum (HS) obtained from untreated hamster heart xen-
ograft recipients was given intravenously (lV}-either un-
altered or C-inactivated by heating at 56°C for 30 minutes. 
Survival of the hamster hearts is shown in Table I. 
Different dilutions of absorbed sera were tested in their 
ability to lyse hamster or mouse lymphocytes in a C-de-
pendent cytotoxicity assay. Hamster serum did not lyse 
hamster cells. While antihamster HS and normal rat serum 
produced efficient lysis of hamster lymphocytes. that pro-
duced by OL T serum was poor. In contrast. OL T serum 
caused efficient lysis of mouse target cells. In conclusion. 
the homology of C and target cells represents a novel 
mechanism of protection that the liver confers to other 
organs. 
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Table 1. Survival of Hamster Heart Xenografts In Liver Xenograft Recipients Injected With Active or Decomplemented Rat 
Antlhamster Hyperlmmune Serum 
Heart Recipients 
Transferred Hyperimmune Serum 
(Immunosuppression) Active (MST:!: SO) Inactive (MST:!: SO) 
1. Normal LEW' (none) 2. 2, 2. 3, 3 min (2.4 ± 0.5) B. 10. 15. 1B. 32 min (16.6 ± 9.4) 
2. LEW rat (eyp B mg/kg per day x 10 + 2. 2, 3. 3, 4 min (2.B ± O.B) 6,12,12,21,28 min (15.B ± B.6) 
FK 506 1 mg/kg per day x 3O)f 
3. OL T ratU (CyP + FK 506) 7, B. 12, 16,32 min (15.1 ± 10.1) 23.23,25,27, 2B days (25.2 ± 2.2) 
'LEW rat recipients normally reject hamster hearts in a mean of 3.0 days. 
tpretreatment. This kind of pretreatment normally extends sulVival of hamster hearts beyond 3 days. 
*LEW rats that received a hamster liver transplant 40 to 60 days before and were immunosuppresaed with CyP and FK 506 as in group 2 for 30 days. w~h no treatment 
thereafter. The preexisting liver xenogral\s were not adversely affected at the time 01 heart rejection using inactivated HS. With active HS. the livers of 4 of 5 rats undelWent 
humoral rejection in less than 24 hours. and the fifth rat survived another 50 days. 
'when unaltered (n = 5) or decomplemented (n - 5) normal rat serum was given instead of HS. Heart xenograft survival was unaffected in group 1 (3 days) and in 
group 3 (25 days). 
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